Elanco | Products and Solutions to Enhance Animal Health (2024)

FAQs

What does Elanco Animal Health do? ›

Elanco is a global leader in animal health dedicated to innovating and delivering products and services to prevent and treat disease in farm animals and pets, creating value for farmers, pet owners, veterinarians, stakeholders, and society as a whole.

Elanco Animal Health Incorporated is an American pharmaceutical company which produces medicines and vaccinations for pets and livestock. Until 2019, the company was a subsidiary of Eli Lilly and Company, before being divested. It is the third-largest animal health company in the world. Greenfield, Indiana, U.S.

Pet health is much more than preventative medicine, and at Elanco we are also focused on providing innovative treatments to support pets with chronic diseases such as skin allergies, osteoarthritis and heart disease.

Tapeworms in cats are a common concern, and Elanco's tapeworm dewormer medicine is an effective way to remove common tapeworms from cats.

For our customers, we promise to be your advocate and continually earn your trust, improving the health of animals, and creating value through innovative products, expertise and service. We find ways to add value with every customer engagement, addressing what matters most, and constantly raising the bar.

Elanco Completes Separation from Lilly

Elanco becomes a fully-independent pure play animal health company.

Elanco main competitors are Warner Chilcott, Merck, and U.S. Pharmacopeia. Competitor Summary. See how Elanco compares to its main competitors: Roche Holding AG has the most employees (94,442).

One of the most significant changes Elanco announced was its acquisition of Bayer Animal Health in 2019. The acquisition was completed in August 2020 and catapulted Elanco to the forefront of the animal health industry. Now that the merger is complete, what can investors expect the combined company to do in 2021?

Fourth Quarter 2023 Financial Results: Revenue of $1,035 million. Reported Net Loss of $141 million, Adjusted Net Income of $39 million.

We are providing engineering services for Elanco Animal Health Corporate Headquarters in Indianapolis, Indiana.

What are the side effects of Elanco? ›

SIDE EFFECTS:

Isolated incident of either salivation, vomiting, diarrhea, poor appetite or listlessness have been reported following treatment, but were considered non-significant. If these signs are observed and they persist, consult your veterinarian.

We Are Elanco

At Elanco, we have nearly 10,000 employees across the world.

Possible side effects are decreased appetite, vomiting, diarrhea, changed stool color, change in drinking or urination, behavioral changes such as depression or restlessness. For complete safety information, please see ONSIOR product label or ask your veterinarian. Elanco Animal Health. Market Data on File.

For this reason, your vet is likely to recommend deworming your cat monthly.

Animal health manufacturers are biopharmaceutical companies that invest in research and development to create innovative medicines for food-producing and companion animals.

Elanco prides itself on consistently high audit results. We only work with research partners that meet our high standards of animal welfare and ensure all animal studies are subjected to ethical oversight.

Pharmaceuticals help animals live longer, higher-quality lives by addressing infections, diabetes, obesity, pain, cancer and age-related diseases. Just as humans rely on doctors to diagnose ailments and prescribe treatments, animals need veterinarians to manage many types of pharmaceutical treatments.